Who is on it, and how far along Every drug ChEMBL records acting on RARA, by the furthest stage it has reached for any use, coloured by modality.
How to read this Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
Approved4 Tretinoin Tretinoin SponsorBausch Health ModalitySmall molecule ActionAgonist Open trials63 Isotretinoin Isotretinoin SponsorRoche ModalitySmall molecule ActionAgonist Open trials28 Adapalene Adapalene SponsorGalderma Laboratories ModalitySmall molecule ActionAgonist Open trials15 Tazarotene Tazarotene SponsorChartwell RX ModalitySmall molecule ActionAgonist Open trials0 Phase 11 IRX4310 IRX4310 SponsorNot known ModalityOther ActionAntagonist Open trials0
Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 4 of 5 act as: Retinoic acid receptor agonist; the rest name their own mechanism. The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 24 in all, from ClinicalTrials.gov. Trial Drug Phase Status Lead sponsor First posted Combined Tretinoin and Tranexamic Acid Cream for Hyperpigmentation After Electrosurgery Tretinoin Phase 2 Recruiting Wahyu Lestari Nov 19, 2026 Naxitamab Enabled Transplant-Free Study in High-Risk Neuroblastoma Isotretinoin Phase 2 Recruiting Giselle Sholler Nov 12, 2026 Clinical Evaluation of an Oil-Balancing Facial Sunscreen With Topical Tretinoin Tretinoin Phase 4 Enrolling by invitation Colgate Palmolive Nov 12, 2026 Salicylic Acid Solution Versus Tretinoin 0.05% Cream for Treating Plane Warts Tretinoin Not applicable Not yet recruiting Combined Military Hospital, Pakistan Nov 10, 2026 Palbociclib, All-Trans Retinoic Acid, and Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia Tretinoin Phase 1 / Phase 2 Not yet recruiting Second Affiliated Hospital of Nanchang University Nov 9, 2026 Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris Adapalene Phase 4 Recruiting IR INNOVATE RESEARCH PRIVATE LIMITED Nov 5, 2026 Comparing Nadifloxacin Plus Tretinoin Versus Clindamycin Plus Tretinoin Creams for Mild-to-Moderate Acne Tretinoin Phase 4 Recruiting Nishtar Medical University Nov 4, 2026 Adapalene Gel for Acute Radiation-Induced Skin Injury Adapalene Early phase 1 Recruiting Yunnan Cancer Hospital Oct 21, 2026 Comparison of Topical Clascoterone 1% Cream Versus Adapalene 0.1% Cream in the Treatment of Mild-to-Moderate Acne Vulgaris Adapalene Not applicable Recruiting Pak Emirates Military Hospital Oct 20, 2026 Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial Acne Adapalene Phase 4 Not yet recruiting Allied Hospital Faisalabad Oct 19, 2026 Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of Ependymoma Tretinoin Phase 1 / Phase 2 Not yet recruiting Children's Oncology Group Sep 30, 2026 Phase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI Resistance Tretinoin Phase 1 Not yet recruiting Cancer Institute and Hospital, Chinese Academy of Medical Sciences Sep 25, 2026 Facial Skin Microbiome in Patients With Moderate-to-Severe Acne Vulgaris Treated With Isotretinoin Isotretinoin — Recruiting Can Tho University of Medicine and Pharmacy Sep 22, 2026 The Impact of Baseline Hormonal Profiles (DHEAS, FSH, LH) on Treatment Response to Systemic Isotretinoin in Adult Female Patients With Acne Vulgaris Isotretinoin — Recruiting Biruni University Sep 14, 2026 Radiofrequency Treatment Versus Topical Therapy for Facial Acne Vulgaris Adapalene Not applicable Recruiting Jeisys Medical Inc Sep 4, 2026 Topical Metformin Versus Triple Regimen for Epidermal Melasma Tretinoin Phase 2 Not yet recruiting Combined Military Hospital, Pakistan Aug 21, 2026 Comparison of Itraconazole With Itraconazole and Isotretinoin in the Treatment Duration, Safety a n d Cure Rate in Adult Patients of Tinea Corporis/ Cruris-A Randomised Controlled Trail Isotretinoin Phase 4 Not yet recruiting Pak Emirates Military Hospital Jun 30, 2026 Comparison of Topical Clascoterone and Adapalene for Mild Acne Vulgaris Adapalene Early phase 1 Not yet recruiting Khyber Teaching Hospital Jun 29, 2026 Low-Dose Versus Conventional-Dose Oral Isotretinoin for Acne Vulgaris Isotretinoin Phase 4 Not yet recruiting Pakistan Institute of Medical Sciences Jun 10, 2026 Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway Isotretinoin Phase 2 Not yet recruiting University of California, San Francisco Jun 5, 2026 Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo Adapalene Phase 4 Recruiting Bausch Health Americas, Inc. Apr 13, 2026 Isotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm Isotretinoin Phase 2 Enrolling by invitation University of Nebraska Mar 18, 2026 Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study Adapalene Phase 2 Not yet recruiting Assiut University Mar 16, 2026 Efficacy of Cosmetic Product RV3278B-OS0386 in the Maintenance Phase After Oral Isotretinoin Treatment of Adults Subjects With Facial Acne. Isotretinoin Not applicable Active, not recruiting Pierre Fabre Dermo Cosmetique Jan 14, 2026
Show all 24Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2363069 , ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov , checked daily; this page as of 2026-11-21. ChEMBL and Open Targets